search
Back to results

Mechanisms of Refractory Hypertension (High and Low Salt Diet)

Primary Purpose

Hypertension

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
NaCl tablets
Sponsored by
University of Alabama at Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension

Eligibility Criteria

19 Years - 80 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult subjects ≥ 19 years of age
  • Refractory hypertension defined as office BP > 140/90 that is uncontrolled with at least 5 different classes of antihypertensive medications
  • Self-reported adherence >80% with prescribed antihypertensive medications

Exclusion Criteria:

  • Severe hypertension (office BP >160/100 mm Hg)
  • History of congestive heart failure (ejection fraction of <40%)
  • Chronic kidney disease (creatinine clearance <60 ml/min)
  • History of cardiovascular disease (stroke, TIA, myocardial infarction, or revascularization procedure)
  • White coat hypertension defined as office BP >140/90 mm Hg and ambulatory daytime BP <135/85 mm Hg
  • Pregnant or nursing women

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Low salt diet

    High salt diet

    Arm Description

    The low-salt meals will be formulated to provide 50 mmol of sodium per day. Two diets with different caloric amounts (2000 or 2500) will be available.

    High dietary salt intake, NaCl tablets (6 grams/day) will added to the subject's study diet in order to increase dietary sodium intake to >250 mmol/day.

    Outcomes

    Primary Outcome Measures

    Change in 24-hour ambulatory systolic blood pressure (BP).
    The mean change in blood pressure for each group after receiving 4 weeks of either a low salt diet compared to High dietary salt intake. The low-salt meals will be formulated to provide 50 mmol of sodium per day. Two diets with different caloric amounts (2000 or 2500) will be available. High dietary salt intake, NaCl tablets (6 grams/day) will added to the subject's study diet in order to increase dietary sodium intake to >250 mmol/day.

    Secondary Outcome Measures

    Full Information

    First Posted
    January 22, 2015
    Last Updated
    June 10, 2020
    Sponsor
    University of Alabama at Birmingham
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02357017
    Brief Title
    Mechanisms of Refractory Hypertension (High and Low Salt Diet)
    Official Title
    Mechanisms of Refractory Hypertension (High and Low Salt Diet)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2020
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Change in priority of interventional protocols
    Study Start Date
    February 2015 (undefined)
    Primary Completion Date
    January 31, 2020 (Actual)
    Study Completion Date
    January 31, 2020 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Alabama at Birmingham

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of the study is to test the hypothesis that persistent fluid retention and high sympathetic output contributes to the development of refractory hypertension (HTN). The investigators will determine, in a cross-over assessment of high and low salt diets, if dietary sodium restriction reduces 24-hr ambulatory BP in patients with refractory HTN. Moreover, the investigators will determine if dietary sodium restriction lessens the severity of obstructive sleep apnea (OSA) in patients with refractory HTN.
    Detailed Description
    We are proposing a unique phenotype of antihypertensive treatment failure that we refer to as refractory HTN. We have come to feel that while resistant (RHTN) represents a broad phenotype with multiple and overlapping etiologies of treatment resistance, there is a unique subset of patients who never achieve BP control in spite of maximal therapy. In a recently published retrospective analysis of our clinic experience, we found that patients with refractory HTN comprised about 10% of patients referred to us for RHTN. A large number of intervention studies have verified the benefit of dietary salt restriction to reduce BP. We made such an assessment in a prospective, randomized, cross-over comparison of high- and low salt diets in 12 patients with confirmed RHTN. The average reduction in BP going from high to the low salt diet was 23/10 mmHg in the clinic and 20/10 mmHg during 24-hr ambulatory BP monitoring. These dramatic results demonstrated that patients with RHTN are exquisitely salt-sensitive and highlight the degree of BP reduction that can be accomplished with meaningful salt restriction. However, we are proposing the novel hypothesis that refractory HTN is mechanistically unique from RHTN in that it is not secondary to recalcitrant fluid retention. Determining an association between dietary salt restriction and severity of obstructive sleep apnea (OSA) would potentially help us to find new therapies guided towards achieving better control of BP in patients with refractory HTN. We will investigate the effect of dietary salt intake on severity of OSA vascular function in patients with refractory HTN by doing vascular studies (pulse wave analysis/velocity, calculating thoracic impedance)).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hypertension

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Low salt diet
    Arm Type
    Active Comparator
    Arm Description
    The low-salt meals will be formulated to provide 50 mmol of sodium per day. Two diets with different caloric amounts (2000 or 2500) will be available.
    Arm Title
    High salt diet
    Arm Type
    Active Comparator
    Arm Description
    High dietary salt intake, NaCl tablets (6 grams/day) will added to the subject's study diet in order to increase dietary sodium intake to >250 mmol/day.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    NaCl tablets
    Primary Outcome Measure Information:
    Title
    Change in 24-hour ambulatory systolic blood pressure (BP).
    Description
    The mean change in blood pressure for each group after receiving 4 weeks of either a low salt diet compared to High dietary salt intake. The low-salt meals will be formulated to provide 50 mmol of sodium per day. Two diets with different caloric amounts (2000 or 2500) will be available. High dietary salt intake, NaCl tablets (6 grams/day) will added to the subject's study diet in order to increase dietary sodium intake to >250 mmol/day.
    Time Frame
    baseline to 4 weeks

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    19 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Adult subjects ≥ 19 years of age Refractory hypertension defined as office BP > 140/90 that is uncontrolled with at least 5 different classes of antihypertensive medications Self-reported adherence >80% with prescribed antihypertensive medications Exclusion Criteria: Severe hypertension (office BP >160/100 mm Hg) History of congestive heart failure (ejection fraction of <40%) Chronic kidney disease (creatinine clearance <60 ml/min) History of cardiovascular disease (stroke, TIA, myocardial infarction, or revascularization procedure) White coat hypertension defined as office BP >140/90 mm Hg and ambulatory daytime BP <135/85 mm Hg Pregnant or nursing women
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    David A. Calhoun, MD
    Organizational Affiliation
    Cardiology Department - University of Alabama at Birmingham
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Mechanisms of Refractory Hypertension (High and Low Salt Diet)

    We'll reach out to this number within 24 hrs